Phase 1 / Phase 2CompletedINTERVENTIONAL
Exenatide Once Weekly for Smoking Cessation
ClinicalTrials.gov · NCT02975297 · Registry updated: 2021-01-28
- Condition / research focus
- Smoking Cessation
- Sponsor
- The University of Texas Health Science Center, Houston
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2016-07. Completion: 2020-01-03 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Exenatide (drug) — also listed as: Bydureon
- NRT (drug) — also listed as: Nicotine patch
- Counseling (behavioral) — also listed as: Smoking cessation counseling
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Houston, Texas, United States